Benjamin Kopp, MD, MPH, is the Director of the Pulmonary Sickle Cell Program at Children's Healthcare of Atlanta. He also serves as Co-Director of Emory University and Children’s Cystic Fibrosis and Airway Disease Research Center.
Dr. Kopp is a graduate of The Ohio State University School of Medicine. He received his Master of Public Health from The Ohio State University College of Public Health prior to completing his pediatrics residency and pulmonology fellowship at Nationwide Children’s Hospital in Columbus, Ohio. Dr. Kopp then completed post-doctoral training in bacterial pathogenesis and macrophage biology in the laboratories of Amal Amer and Larry Schlesinger.
Dr. Kopp’s area of clinical expertise includes cystic fibrosis, sickle cell lung disease and long-term respiratory sequelae of viral infections such as COVID-19. Dr. Kopp’s NIH-funded research program focuses on innate immune regulation of chronic lung disease in children with cystic fibrosis and sickle cell. An important aspect of this research includes the impact of secondhand tobacco and vape exposure on airway infections and inflammation.
His advocacy and public health efforts center on increasing care for underserved populations and public policy to prevent climate change and environmental exposure impacts on respiratory health.
Focus of Practice
- Cystic fibrosis
- Sickle cell lung disease
Areas of Interest
- Respiratory complications of COVID-19
- Cystic fibrosis
- Lung immunology
Childrens Physician Group - PulmonologyCenter for Advanced Pediatrics, 1400 Tullie Road NE 5th Floor Atlanta, GA 30329 Get Directions 404-785-5437
Childrens Physician Group - Emergency MedicineEgleston hospital, 1405 Clifton Rd NE Atlanta, GA 30322 Get Directions 404-785-8010
Childrens Physician Group - Hospitalists at EglestonEgleston hospital, 1405 Clifton Rd NE Tower 2 Ground Floor Atlanta, GA 30322 Get Directions 404-785-6104
Research & Publications
Dr. Kopp’s research interests include host-directed therapies for cystic fibrosis, longitudinal evolution of sickle cell lung disease, and lung immunology.